Human adenosine 2B receptor: SNP discovery and evaluation of expression in patients with cystic fibrosis

Pharmacogenetics and Genomics

Volumn 15, Issue 5, 2005, Pages 321-327

  Tang, Chih Min ^a   Hoerning, André ^b   Büscher, Rainer ^b   O'Connor, Daniel T ^a   Ratjen, Felix ^b   Grasemann, Hartmut ^b   Insel, Paul A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Adenosine 2B receptor; African American; Caucasian; Cystic fibrosis; Exon splicing enhancer activity; SNP

Indexed keywords

ADENOSINE 2B RECEPTOR; ADENOSINE RECEPTOR; ARGININE; GENE PRODUCT; GLYCINE; LEUCINE; PHENYLALANINE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADENOSINE 2B RECEPTOR GENE; ADULT; AFRICAN AMERICAN; ALLELISM; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; ETHNIC DIFFERENCE; EUROPE; EXON; FEMALE; GENE FREQUENCY; GERMANY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OPEN READING FRAME; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 18744365191     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200505000-00007     Document Type: Article

References (33)

1. Fredholm BB. Adenosine receptors as targets for drug development. Drug News Perspect 2003; 16:283-289.
2. Feoktistov I, Biaggioni I. Adenosine A2B Receptors. Pharmacol Rev 1997; 49:381-402.
3. Jacobson MA, Johnson RG, Luneau CJ, Salvatore CA. Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene. Genomics 1995; 27:374-376.
4. Van Heeke G, Seamons R, Matais J-Y, Fozard JR, Goff S, Wheatley A, et al. Single nucleotide polymorphism analysis of the human adenosine A2B receptor gene: prevalence of SNPs in asthmatics and normal subjects. Gene Funct Dis 2002; 3:87-92.
5. Ochi M, Shiozaki S, Kase H. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease. Neuroscience 2004; 127:223-231.
6. Baxter GF. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res 2002; 55:483-494.
7. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 2001; 104:2981-2989.
8. Dubey RK, Gillespie DG, Jackson EK. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors. Hypertension 1998; 31:943-948.
9. Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W, et al. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2004; 287:H2478-2486.
10. Yan L, Muller CE. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. J Med Chem 2004; 47:1031-1043.
11. Mundell SJ, Olah ME, Panettieri RA, Benovic JL, Penn RB. Regulation of G protein-coupled receptor-adenylyl cyclase responsiveness in human airway smooth muscle by exogenous and autocrine adenosine. Am J Respir Cell Mol Biol 2001; 24:155-163.
12. Zhong H, Belardinelli L, Maa T, Feoktistov I, Biaggioni I, Zeng D. A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 2004; 30:118-125.
13. Huang P, Lazarowski ER, Tarran R, Milgram SL, Boucher RC, Stutts MJ. Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc Natl Acad Sci U S A 2001; 98:14120-14125.
14. Lazarowski ER, Tarran R, Grubb BR, van Heusden CA, Okada S, Boucher RC. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem 2004; 279:36855-36864.
15. Bucheimer RE, Linden J. Purinergic regulation of epithelial transport. J Physiol 2004; 555:311-321.
16. Büscher R, Eilmes KJ, Grasemann H, Torres B, Knauer N, Sroka K, et al. β2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 2002; 12:347-353.
17. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3:285-298.
18. Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE, et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 2004; 29:558-565.
19. Alsene K, Deckert J, Sand P, de Witt H. Association between A2a receptor gene polymorphism and caffeine-induced anxiety. Neuropsychopharmacology 2003; 28:1694-1702.
20. Iida A, Saito S, Sekine A, Kataoka Y, Tabei W, Nakamura Y. Catalog of 300 SNPs in 23 genes encoding G-protein coupled receptors. J Hum Genet 2004; 49:194-208.
21. Brodde OE, Büscher R, Tellkamp R, Radke J, Dhein S, Insel PA. Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors. Circulation 2001; 27:1048-1050.
22. Rana BK, Shiina T, Insel PA. Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu Rev Pharmacol Toxicol 2001; 41:593-624.
23. Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004; 23:6471-6476.
24. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, et al. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998; 102:1534-1539.
25. Kirstein SL, Insel PA. Autonomic nervous system pharmacogenomics: a progress report. Pharmacol Rev 2004; 56:31-52.
26. Oguma T, Palmer LJ, Birben E, Sonna LA, Asano K, Lilly CM. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 2004; 351:1752-1763.
27. Parola AL, Kobilka BK. The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 1994; 269:4497-4505.
28. Lee A, Rana BK, Schiffer HH, Schork NJ, Brann MR, Insel PA, et al. Distribution analysis of nonsynonymous polymorphisms within the G-protein-coupled receptor gene family. Genomics 2003; 81:245-248.
29. Cui J, Zhou X, Chazaro I, DeStefano AL, Manolis AJ, Baldwin CT, et al. Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. Am J Hypertens 2003; 16:859-863.
30. Salisbury BA, Pungliya M, Choi JY, Jiang R, Sun XJ, Stephens JC. SNP and haplotype variation in the human genome. Mutat Res 2003; 526:53-61.
31. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC and Richter DJ. Linkage disequilibrium in the human genome. Nature 2001; 411:199-204.
32. Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A. Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 2003; 12:771-776.
33. Hamosh A, FitzSimmons SC, Macek M Jr, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 1998; 132:255-259.